Medicare Enrolled
Dr. Amy Tobin, DO
Endocrinology · Sterling Heights, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tobin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tobin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tobin
Dr. Amy Tobin is an endocrinology specialist in Sterling Heights, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tobin performed 885 Medicare services across 426 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tobin received a total of $35,131 from 75 pharmaceutical and/or device companies across 1193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tobin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 38% volume in MI
$35,131 industry payments
Medicare Practice Summary
Medicare Utilization ↗885
Medicare services
Top 38% in MI for endocrinology
426
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
301 | $95 | $183 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
200 | $9 | $25 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
128 | $27 | $85 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
111 | $4 | $20 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
58 | $6 | $11 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
58 | $5 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $124 | $281 |
| New patient office visit, complex (60-74 min) | 12 | $167 | $347 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$35,131
Total received (2018-2024)
Avg $5,019/year across 7 years
Top 13% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
1,193
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,733 (96.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,348 (3.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,112
2023
$4,569
2022
$5,344
2021
$4,357
2020
$2,712
2019
$7,566
2018
$4,471
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,348
CeQur Corporation
$1,168
Novo Nordisk Inc
$667
Lilly USA, LLC
$450
Medtronic, Inc.
$432
Amgen Inc.
$353
Dexcom, Inc.
$265
Boehringer Ingelheim Pharmaceuticals, Inc.
$180
SANOFI-AVENTIS U.S. LLC
$177
Corcept Therapeutics
$176
Bayer Healthcare Pharmaceuticals Inc.
$118
Xeris Pharmaceuticals, Inc.
$90
Mannkind Corporation
$74
ABBVIE INC.
$72
Ascensia Diabetes Care Us Inc.
$69
Amneal Pharmaceuticals LLC
$54
Insulet Corporation
$53
Neurocrine Biosciences, Inc.
$49
Alvogen Inc
$47
Ultragenyx Pharmaceutical Inc.
$44
Chiesi USA, Inc.
$35
Amphastar Pharmaceuticals, Inc.
$33
Alexion Pharmaceuticals, Inc.
$26
RECORDATI_RARE_DISEASES_INC.
$23
Tandem Diabetes Care, Inc.
$22
Esperion Therapeutics, Inc.
$17
IBSA Pharma Inc.
$17
Radius Health, Inc.
$16
Tolmar, Inc.
$16
BETA BIONICS, INC.
$12
TheracosBio, LLC
$10
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$4,436
Medtronic, Inc.
$3,527
Abbott Laboratories
$2,650
Medtronic MiniMed, Inc.
$2,483
Amgen Inc.
$2,356
AstraZeneca Pharmaceuticals LP
$2,290
Lilly USA, LLC
$2,217
CeQur Corporation
$1,656
SANOFI-AVENTIS U.S. LLC
$1,332
Dexcom, Inc.
$1,153
Tandem Diabetes Care, Inc.
$809
Mannkind Corporation
$537
Corcept Therapeutics
$492
Xeris Pharmaceuticals, Inc.
$449
Merck Sharp & Dohme Corporation
$449
Boehringer Ingelheim Pharmaceuticals, Inc.
$416
Becton, Dickinson and Company
$389
Radius Health, Inc.
$373
Bayer HealthCare Pharmaceuticals Inc.
$345
AbbVie, Inc.
$332
Bayer Healthcare Pharmaceuticals Inc.
$310
Amarin Pharma Inc.
$307
Janssen Pharmaceuticals, Inc
$293
Shire North American Group Inc
$280
Horizon Therapeutics plc
$276
Amneal Pharmaceuticals LLC
$275
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$246
Antares Pharma, Inc.
$245
DEXCOM, INC.
$239
Insulet Corporation
$239
Ascendis Pharma Inc
$236
Senseonics, Incorporated
$230
VistaPharm, Inc.
$225
Nevro Corp.
$203
MannKind Corporation
$202
Ultragenyx Pharmaceutical Inc.
$187
Valeritas, Inc.
$175
AbbVie Inc.
$166
Esperion Therapeutics, Inc.
$161
LifeScan, Inc.
$153
Alexion Pharmaceuticals, Inc.
$139
Clarus Therapeutics Inc.
$137
ABBVIE INC.
$122
Ipsen Biopharmaceuticals, Inc
$121
Alvogen Inc
$105
RECORDATI_RARE_DISEASES_INC.
$97
LIFESCAN, INC.
$90
PFIZER INC.
$84
Amryt Pharma Holdings Ltd
$75
Embecta Corp.
$72
Ascensia Diabetes Care Us Inc.
$69
IBSA Pharma Inc.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$62
Averitas Pharma Inc.
$55
Neurocrine Biosciences, Inc.
$49
MEDLINE INDUSTRIES LP
$45
Zealand Pharma US, Inc.
$39
VIVUS LLC
$36
Chiesi USA, Inc.
$35
Amphastar Pharmaceuticals, Inc.
$33
GRT US Holding, Inc.
$28
EISAI INC.
$27
Kowa Pharmaceuticals America, Inc.
$24
Bigfoot Biomedical Inc
$23
VIVUS, Inc.
$21
EUSA Pharma (US) LLC
$18
Companion Medical, Inc.
$17
Tolmar, Inc.
$16
Gilead Sciences, Inc.
$15
Roche Diabetes Care, Inc.
$15
Alfasigma USA, Inc.
$13
Strongbridge US INC.
$12
BETA BIONICS, INC.
$12
Aegerion Pharmaceuticals, Inc.
$11
TheracosBio, LLC
$10
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AFREZZA · ASCENDA · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · Brenzavvy · CRENESSITY · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · Cryvista · DC ACCU-CHEK Aviva Connect Kits and Accessories · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FREESTYLE LIBRE PRO · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · Guardian Sensor 3 · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · JUXTAPID · Kerendia · Korlym · Levemir · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · MiniMed Quick-set · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NO PRODUCT DISCUSSED · NOCDURNA · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Otrexup · Ozempic · PRALUENT · Prolia · QSYMIA · QUTENZA · Qsymia · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Somatuline Depot · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
78
Per 100K population
8.9
County median income
$76,399
Nearest hospital
THE BEHAVIORAL CENTER OF MICHIGAN
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tobin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tobin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tobin performed 301 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tobin receive payments from pharmaceutical companies?
Yes. Dr. Tobin received a total of $35,131 from 75 companies across 1,193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tobin's costs compare to other endocrinologists in Sterling Heights?
Dr. Tobin's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tobin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Sterling Heights
Browse endocrinologists in Sterling Heights ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology